Detail akcie cbdMD Rg online

Business Summary: cbdMD, Inc. is a consumer wellness company focused on the development, manufacturing, marketing, and sale of supplement brands powered by natural compounds. Its hemp-derived cannabinoids, include full-spectrum cannabidiol (CBD) formulations, hemp-derived Delta-9 THC products and a range of functional products designed to address key wellness needs, such as sleep, recovery, mood, discomfort, mobility, cognitive function, and stress management. It operates a multi-brand portfolio anchored by its flagship cbdMD line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Its Paw CBD pet-wellness brand provides tinctures, chews, and topicals for dogs and cats. Its ATRX platform offers non-cannabinoid functional ingredients such as functional mushrooms. Its Herbal Oasis (Oasis) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2025, cbdMD Inc revenues decreased 1% to $19.2M. Net loss applicable to common stockholders decreased 43% to $4.4M. Revenues reflect E-commerce sales segment decrease of 6% to $14.7M. Lower net loss reflects Operating expenses - Balancing value decrease of 73% to $558K (expense), Increase in fair value of convertible de increase from $430K (expense) to $87K (income).